ArticleActa pharmacologica Sinica2016

Discovery and structural optimization of 4-(4-(benzyloxy)phenyl)-3,4-dihydropyrimidin-2(1H)-ones as RORc inverse agonists.

Xi-Shan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.